Cal-Maine Foods reported second-quarter earnings per share of $2.13, topping the analyst consensus of $2.01, while generating revenue of $769.5 million versus the forecasted $826.4 million. Total sales declined more than 19% year over year, reflecting a sharp contraction following record price levels in 2025. The company’s gross margin held at approximately 43.5%, bolstered by strong performance in higher-margin specialty segments, but overall top-line weakness weighed on investor sentiment and triggered a 4.1% intraday stock decline.

Organic, free-range and other specialty egg product lines sustained both volume growth and price stability year over year, according to CEO Sherman Miller. While conventional egg sales plunged 41% amid surplus supply and falling commodity prices, specialty segments offset much of that decline. Volume in the specialty portfolio rose by roughly 8% over the prior-year period, and Miller highlighted ongoing capacity expansions—such as the recent Prepared Foods facility investment—to drive double-digit future volume growth in value-added categories.

After earning nearly $25 per share in fiscal 2025, Cal-Maine is expected to deliver approximately $9.31 per share in 2026, with estimates tapering to $6.67 by 2028. Using the latter forecast, the stock trades at about 11.5 times forward earnings, a valuation roughly in line with its 11% dividend yield. Analysts maintain a conservative stance given the potential for continued commodity price pressure, but note that zero long-term debt and a current ratio north of 6.8 provide financial flexibility. The company’s diversification into specialty and prepared foods is cited as a key element supporting margin stability over the next several years.